report
two
confirm
case
usual
interstiti
pneumonia
uip
associ
infect
human
bocaviru
hbov
one
case
hbov
identifi
bronchoalveolar
lavag
bal
acut
exacerb
well
post
mortem
differ
tissu
give
rais
hypothesi
hbov
infect
trigger
uip
could
caus
agent
system
compon
uip
case
uip
confirm
radiolog
method
hbov
detect
bal
acut
exacerb
case
give
rais
hypothesi
hbov
could
caus
agent
uip
could
contribut
develop
andor
acut
exacerb
elsevi
bv
right
reserv
case
import
human
bocaviru
initi
discov
associ
seriou
infect
respiratori
tract
gastrointestin
diseas
although
koch
postul
could
fulfil
human
bocaviru
far
increas
evid
true
pathogen
rather
innoc
bystand
airway
infect
review
recent
other
shown
acut
hbov
infect
lead
persist
infect
lead
coval
close
circular
hbov
genom
infect
cell
becom
like
hypothesi
chronic
hbov
infect
could
lead
ongo
mayb
subclin
inflamm
process
final
lead
fibrosi
chronic
infect
tissu
observ
dna
virus
like
hepat
b
viru
infect
might
also
specul
persist
infect
hbov
could
respons
chronic
idiopath
interstiti
lung
diseas
usual
interstiti
pneumonia
uip
base
mention
background
knowledg
observ
clinic
case
year
old
caucasian
male
came
hospit
acut
dyspno
base
chronic
interstiti
lung
diseas
histori
patient
formerli
smoker
nonsmok
sinc
sever
year
suffer
nonproduct
cough
chronic
dyspnoea
sever
symptomat
progress
last
year
past
medic
histori
reveal
coronari
heart
diseas
histori
myocardi
infarct
bypass
surgeri
nine
year
ago
associ
risk
factor
includ
arteri
hypertens
diabet
mellitu
hyperlipidemia
histori
smoke
cumul
dosag
pack
year
current
comput
tomographi
ct
scan
thorax
reveal
reticular
abnorm
traction
bronchiectasi
honeycomb
subpleur
basal
predomin
consist
uip
pattern
radiolog
find
consist
progress
uip
known
caus
interstiti
lung
diseas
ild
domest
occup
environment
exposur
connect
tissu
diseas
drug
toxic
evid
blood
ga
analys
reveal
ph
paco
mmhg
pao
mmhg
bicarbon
level
mmoll
lung
function
test
use
spirometri
bodyplethysmographi
demonstr
restrict
pattern
forc
vital
capac
fvc
l
predict
forc
expiratori
volum
fev
l
predict
fev
fvc
ratio
residu
volum
rv
see
front
matter
elsevi
bv
right
reserv
http
l
predict
total
lung
capac
tlc
l
predict
therebi
diffus
capac
serious
impair
krogh
factor
mmolkpamin
predict
base
find
current
recommend
patient
diagnos
uip
patient
receiv
antibiot
therapi
sulaicillin
antifung
therapi
fluconazol
amphotericin
b
steroid
therapi
prednisolon
combin
antifibrot
therapi
azathiotpin
cytolog
bronchoalveolar
lavag
bal
gain
flexibl
bronchoscopi
display
macrophag
lymphocyt
neutrophil
slight
elev
overal
cell
count
million
cell
per
l
nonsmok
statu
sinc
year
number
neutrophil
therebi
count
upper
boarder
normal
rang
also
compat
uip
histopatholog
investig
airway
reveal
sign
mild
chronic
bronchiti
transbronchi
biopsi
perform
microbiolog
virolog
investig
remain
neg
cultur
molecular
method
except
distinct
posit
signal
hbov
luminex
rvp
luminex
tx
usa
pathogen
screen
influenza
virus
hmpv
rsv
piv
hbov
coronavirus
adenovirus
enterorhinovirus
xtag
rvp
hsv
cmv
ebv
vzv
artusqiagen
lcpcr
assay
mycobacterium
tuberculosi
atyp
mycobactria
chipron
mycodirect
assay
respiratori
bacteria
bordetella
pertussi
pcr
haemophilu
influenza
cultur
legionella
pneumophila
antigen
test
mycoplasma
pneumonia
pcr
chlamydophila
pneumonia
pcr
streptococca
cultur
staphylococca
cultur
screen
bacteria
perform
extern
laboratori
provid
servic
hospit
candida
alibican
found
mouth
patient
fungi
detect
bal
cytospin
prepar
routin
stain
haematoxylineosinstain
period
acidschiff
stain
follow
microscop
investig
thu
case
hbov
detect
bal
half
year
later
patient
present
progress
uip
confirm
radiograph
mean
list
lung
transplant
second
case
nonsmok
year
old
caucasian
male
patient
transfer
extern
hospit
treatment
respiratori
failur
interstiti
lung
diseas
known
sever
month
establish
defin
diagnosi
sought
ct
scan
reveal
reticular
abnorm
diffus
honeycomb
also
sever
ground
glass
opac
patient
thought
suffer
respiratori
infect
howev
sequenti
antibiot
antivir
treatment
meropenem
ceftazidimeciprofloxazin
ganciclovir
success
initi
white
blood
cell
count
wbc
increas
maximum
creactiv
protein
reach
valu
mgl
worsen
respiratori
failur
patient
transfer
intens
care
unit
day
intermitt
noninvas
ventil
patient
intub
receiv
invas
mechan
ventil
invas
ventil
flexibl
bronchoscopi
perform
therebi
bal
obtain
demonstr
enhanc
cell
count
mio
cellsml
norm
nonsmok
mio
cellsml
differenti
cytolog
macrophag
lymphocyt
neutrophil
granulocyt
microscop
investig
bal
reveal
numer
erythrocyt
alveolar
macrophag
hint
fungal
infect
pneumocysti
jirovecii
singl
cell
enlarg
nucleu
observ
compat
viral
cytopath
effect
typic
form
owley
cell
known
cmv
infect
granulocytosi
compat
bronchoalveolar
infect
bacteri
origin
lymphocytosi
concert
observ
virocyt
sign
viral
infect
final
superinfect
bacteria
ration
normal
count
slightli
elev
typic
histiocytosi
x
turn
exclud
bal
also
test
posit
pcr
cmv
human
bocaviru
hbov
cmvpcr
qiagen
hilden
germani
luminex
rvp
assay
luminex
austin
tx
respect
although
p
jirovecii
pneumonia
suspect
test
pcr
remain
neg
pathogen
identifi
pcr
microbiolog
screen
howev
clinic
condit
patient
rapidli
deterior
subsequ
patient
die
post
mortem
tissu
sampl
collect
autopsi
formalin
fix
paraffin
embed
test
cmv
hbov
test
tissu
sampl
lung
tissu
right
lower
lobe
heart
septum
pancrea
thyroid
gland
becam
posit
cmv
surprisingli
addit
right
left
ventricl
myocard
test
posit
hbov
formalin
fix
paraffin
embed
tissu
liver
spleen
kidney
left
right
bone
marrow
testi
lymph
node
adren
gland
prostat
gland
remain
neg
virus
final
tissu
sampl
lung
reveal
interstiti
pulmonari
fibrosi
scar
honeycomb
chang
consist
uip
base
find
fulli
exclud
clinic
cours
could
reactiv
cmv
previous
describ
howev
cmv
detect
tissu
sampl
latter
compat
assumpt
local
persist
viru
rather
ubiquit
reactiv
immunosuppress
unfortun
case
imposs
perform
serolog
hbov
screen
blood
sampl
avail
analys
quantif
hbov
perform
case
quantif
hbov
bal
tissu
would
requir
cell
count
tissu
refer
paramet
imposs
count
moreov
quantif
hbov
load
bal
imprecis
instil
volum
strongli
dilut
hbov
titr
infect
tissu
tissu
mucu
thu
perform
addit
headtotail
pcr
posit
bal
indic
presenc
cccdna
patient
surpris
although
bocaviru
shown
persist
inform
avail
literatur
hbov
could
associ
chronic
inflammatori
diseas
could
contribut
chronic
diseas
assum
respect
research
either
ongo
neglect
reason
may
postul
research
hbov
innoc
bystand
rather
seriou
pathogen
first
report
uip
patient
hbov
diagnos
pcr
use
bal
two
patient
uip
diagnos
accord
establish
recommend
recent
acut
hbov
infect
shown
potenti
lead
persist
infect
therebi
hbov
shown
us
other
persist
cccdna
cccdna
also
known
persist
genom
human
hepat
viru
infect
chronic
persist
may
lead
fibrosi
cirrhosi
year
infect
clinic
silent
addit
sever
studi
address
possibl
role
chronic
viral
infect
aetiolog
idiopath
pulmonari
fibrosi
research
focus
epsteinbarr
viru
base
observ
present
find
current
author
would
rais
possibl
hbov
play
signific
role
aetiolog
uip
addit
one
case
autopsi
feasibl
hbov
detect
ventricular
myocard
although
role
observ
still
need
elucid
although
remain
unclear
primari
hbov
occur
report
case
contribut
onset
fibrosi
current
report
identifi
hbov
potenti
agent
caus
uip
possibl
even
heart
diseas
clearli
warrant
systemat
studi
hbov
uip
also
includ
systemat
test
shed
period
viru
although
awar
bia
case
report
correspond
serolog
miss
convinc
present
case
import
trigger
clinic
studi
take
hbov
account
pathogen
may
respons
develop
fibrot
diseas
lung
investig
made
studi
support
research
grant
els
freseniusstiftung
germani
none
author
compet
interest
relev
report
procedur
perform
congruenc
declar
helsinki
accord
vote
ethic
committe
privat
univers
wittenherdeck
vote
